back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-31 10:08 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+99,000 vol |
99,000 | |
| Filed 2024-01-31 10:08 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 10:08 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+201,000 vol |
201,000 | |
| Filed 2024-01-31 10:07 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:33 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+73,700 vol |
73,700 | |
| Filed 2024-01-31 08:33 Tx date 2021-12-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:32 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+36,300 vol |
36,300 | |
| Filed 2024-01-31 08:32 Tx date 2021-12-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:29 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+107,200 vol |
107,200 | |
| Filed 2024-01-31 08:28 Tx date 2021-06-28 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:28 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+52,800 vol |
52,800 | |
| Filed 2024-01-31 08:28 Tx date 2021-06-28 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:55 Tx date 2024-01-30 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
+99,000 vol |
99,000 | |
| Filed 2024-01-30 15:55 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:54 Tx date 2024-01-30 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
56 - Grant of rights
|
+201,000 vol |
201,000 | |
| Filed 2024-01-30 15:53 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:21 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+36,300 vol |
36,300 | |
| Filed 2024-01-30 15:20 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:20 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+73,700 vol |
73,700 | |
| Filed 2024-01-30 15:20 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:18 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+49,500 vol |
49,500 | |
| Filed 2024-01-30 15:18 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:17 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+100,500 vol |
100,500 | |
| Filed 2024-01-30 15:16 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:10 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-27 06:03 Tx date 2023-11-22 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+40,000 vol |
512,000 | |
| Filed 2023-11-24 11:12 Tx date 2023-11-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,688
+21,100 vol $0.08 each |
375,000 | |
| Filed 2023-11-23 11:43 Tx date 2023-11-20 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+20,000 vol $0.07 each |
353,900 | |
| Filed 2023-11-21 10:20 Tx date 2023-11-17 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,940
+249,000 vol $0.06 each |
333,900 | |
| Filed 2023-11-20 06:39 Tx date 2023-11-17 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+450,000 vol |
472,000 | |
| Filed 2022-12-18 12:41 Tx date 2022-12-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
99,828 | |
| Filed 2022-12-18 12:36 Tx date 2022-12-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
135,000 | |
| Filed 2022-12-18 12:36 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
60,000 | ||
| Filed 2022-12-18 12:18 Tx date 2022-12-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
425,000 | |
| Filed 2022-12-18 12:18 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2022-12-16 17:51 Tx date 2022-12-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
375,000 | |
| Filed 2022-12-16 16:43 Tx date 2022-12-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
200,000 | |
| Filed 2022-12-16 10:56 Tx date 2022-12-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
400,000 | |
| Filed 2022-12-16 10:56 Tx date 2022-12-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
||
| Filed 2022-09-19 08:44 Tx date 2022-09-15 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Control or Direction)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$17,000
+25,000 vol $0.68 each |
25,000 | |
| Filed 2022-09-19 08:43 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-09-19 08:41 Tx date 2022-09-15 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Control or Direction)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$13,750
+25,000 vol $0.55 each |
84,900 | |
| Filed 2022-09-15 13:47 Tx date 2022-09-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Holder: Equasy Enterprises Ltd. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+60,000 vol |
75,125 | |
| Filed 2022-09-15 13:47 Tx date 2022-09-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Holder: Equasy Enterprises Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$33,000
+60,000 vol $0.55 each |
140,250 | |
| Filed 2022-06-22 16:16 Tx date 2022-06-22 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,260
+2,000 vol $0.63 each |
59,900 | |
| Filed 2022-06-22 16:15 Tx date 2022-06-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,355
+8,500 vol $0.63 each |
57,900 | |
| Filed 2022-06-17 10:05 Tx date 2022-06-17 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,500
+10,000 vol $0.55 each |
49,400 | |
| Filed 2022-05-25 08:49 Tx date 2022-05-24 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$756.00
+600 vol $1.26 each |
530,725 | |
| Filed 2022-05-25 08:48 Tx date 2022-05-24 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$625.00
+500 vol $1.25 each |
530,125 | |
| Filed 2022-04-19 15:33 Tx date 2022-04-18 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$612.00
+400 vol $1.53 each |
529,225 | |
| Filed 2022-04-19 15:33 Tx date 2022-04-18 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$765.00
+500 vol $1.53 each |
528,825 | |
| Filed 2022-04-04 11:10 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Holder: John Papastergiou Pharmacy Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+31,250 vol $1.60 each |
31,250 | |
| Filed 2022-03-29 09:11 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Holder: John Papastergiou Pharmacy Limited (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+15,625 vol |
15,625 | |
| Filed 2022-03-29 09:10 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Holder: John Papastergiou Pharmacy Limited (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-29 09:10 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Holder: John Papastergiou Pharmacy Limited (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,000
+31,250 vol $0.16 each |
31,250 | |
| Filed 2022-03-29 09:10 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Holder: John Papastergiou Pharmacy Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-25 15:49 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+156,250 vol |
989,583 | |
| Filed 2022-03-25 15:48 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$500,000
+312,500 vol $1.60 each |
2,403,550 | |
| Filed 2022-03-25 15:47 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+156,250 vol |
||
| Filed 2022-03-25 15:46 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+312,500 vol $1.60 each |
||
| Filed 2022-03-25 15:43 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+156,250 vol |
||
| Filed 2022-03-25 15:42 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+312,500 vol $1.60 each |
||
| Filed 2022-03-25 15:33 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+312,500 vol $1.60 each |
||
| Filed 2022-03-25 15:31 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+312,500 vol $1.60 each |
||
| Filed 2022-03-22 18:20 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$17,160
+7,800 vol $2.20 each |
7,800 | |
| Filed 2022-03-22 18:17 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Holder: Equasy Enterprises Ltd. (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+15,125 vol |
15,125 | |
| Filed 2022-03-22 18:17 Tx date 2021-06-28 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Holder: Equasy Enterprises Ltd. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-22 18:16 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Holder: Equasy Enterprises Ltd. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$48,400
+30,250 vol $1.60 each |
80,250 | |
| Filed 2022-03-22 18:15 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-22 18:13 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$24,960
+15,600 vol $1.60 each |
539,154 | |
| Filed 2022-03-22 18:10 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+7,800 vol |
7,800 | |
| Filed 2022-03-22 18:10 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-22 18:09 Tx date 2022-03-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$24,960
+15,600 vol $1.60 each |
528,325 | |
| Filed 2022-03-21 10:36 Tx date 2022-03-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+156,250 vol |
||
| Filed 2022-03-21 10:35 Tx date 2022-03-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+312,500 vol $1.60 each |
||
| Filed 2022-03-18 22:52 Tx date 2022-03-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+156,250 vol |
||
| Filed 2022-03-18 22:51 Tx date 2022-03-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+312,500 vol $1.60 each |
||
| Filed 2022-03-18 22:52 Tx date 2022-03-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Warrants
11 - Acquisition or disposition carried out privately
|
+156,250 vol |
989,583 | |
| Filed 2022-03-18 22:51 Tx date 2022-03-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$500,000
+312,500 vol $1.60 each |
2,403,550 | |
| Filed 2022-01-25 15:25 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
833,333 | ||
| Filed 2022-01-25 15:23 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
OrbiMed Capital LLC
3 - 10% Security Holder of Issuer
Holder: The Biotech Growth Trust PLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,091,050 | ||
| Filed 2022-01-25 14:40 Tx date 2021-12-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
35,172 | ||
| Filed 2022-01-25 14:40 Tx date 2021-12-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
24,828 | ||
| Filed 2022-01-25 14:39 Tx date 2021-12-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-24 16:02 Tx date 2022-01-24 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,135
+1,000 vol $2.13 each |
39,400 | |
| Filed 2022-01-24 09:22 Tx date 2022-01-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,013
+2,125 vol $2.36 each |
512,725 | |
| Filed 2022-01-19 23:56 Tx date 2022-01-19 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,570
+1,000 vol $2.57 each |
38,400 | |
| Filed 2022-01-19 08:54 Tx date 2022-01-18 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,292
+2,100 vol $2.52 each |
37,400 | |
| Filed 2022-01-17 17:14 Tx date 2022-01-17 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,900
+6,000 vol $2.65 each |
35,300 | |
| Filed 2021-12-09 09:21 Tx date 2021-11-30 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Butler, Kate
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2021-08-16 11:22 Tx date 2021-08-13 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,075
+18,500 vol $1.95 each |
18,500 | |
| Filed 2021-08-16 11:19 Tx date 2021-08-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,965
+3,500 vol $1.99 each |
22,000 | |
| Filed 2021-08-11 16:45 Tx date 2021-08-11 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,128
+4,600 vol $1.77 each |
523,554 | |
| Filed 2021-07-22 17:53 Tx date 2021-07-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,440
+800 vol $1.80 each |
510,600 | |
| Filed 2021-07-22 17:52 Tx date 2021-07-21 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,406
+800 vol $1.76 each |
509,800 | |
| Filed 2021-07-21 08:30 Tx date 2021-07-20 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,700
+11,800 vol $1.50 each |
29,300 | |
| Filed 2021-07-19 16:24 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Alpha Tango Ltd (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2021-07-19 16:22 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Alpha Tango Ltd (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,510,706 | ||
| Filed 2021-07-19 16:20 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-19 11:18 Tx date 2021-06-28 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
120,000 | ||
| Filed 2021-07-19 11:17 Tx date 2021-06-28 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Holder: Equasy Enterprises Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-07-19 09:06 Tx date 2021-07-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,880
+1,000 vol $1.88 each |
509,000 | |
| Filed 2021-07-18 20:28 Tx date 2021-07-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,800
+2,000 vol $1.90 each |
17,500 | |
| Filed 2021-07-15 16:04 Tx date 2021-07-15 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,980
+1,000 vol $1.98 each |
15,500 | |
| Filed 2021-07-14 09:21 Tx date 2021-07-13 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+2,000 vol $2.00 each |
508,000 | |
| Filed 2021-07-13 23:41 Tx date 2021-07-13 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+3,000 vol $2.00 each |
14,500 | |
| Filed 2021-07-13 16:56 Tx date 2021-07-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,045
+1,000 vol $2.05 each |
506,000 | |
| Filed 2021-07-13 16:55 Tx date 2021-07-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+2,000 vol $2.00 each |
505,000 | |
| Filed 2021-07-13 00:21 Tx date 2021-07-12 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,014
+1,500 vol $2.01 each |
11,500 | |
| Filed 2021-07-07 13:44 Tx date 2021-07-06 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,140
+1,000 vol $2.14 each |
503,000 | |
| Filed 2021-07-07 13:44 Tx date 2021-07-06 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,340
+2,000 vol $2.17 each |
502,000 | |
| Filed 2021-07-07 09:57 Tx date 2021-07-06 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,500
+10,000 vol $2.15 each |
10,000 | |
| Filed 2021-07-07 09:56 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Holder: 2472199 Ontario Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-29 17:01 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,000 | ||
| Filed 2021-06-18 11:43 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Papastergiou, John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-24 11:39 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2021-06-24 11:39 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Holder: Buyup Holdco Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2021-06-24 11:38 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Scorsis, George
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2021-06-24 11:18 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Sessa, DR BENJAMIN ST. JOHN
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2021-06-24 11:18 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Sessa, DR BENJAMIN ST. JOHN
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,230,000 | ||
| Filed 2021-06-23 17:15 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Collins, James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
210,000 | ||
| Filed 2021-06-23 17:14 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Collins, James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2021-06-23 14:38 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
| Filed 2021-06-23 14:37 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
518,954 |